BackKissei Pharmaceutical , Ltd. Overview

Kissei Pharmaceutical , Ltd. Long Term Debt

Track Kissei Pharmaceutical , Ltd.'s long-term debt ($460M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$464.62M

Peer trimmed avg / median

Loading

Kissei Pharmaceutical , Ltd. Long Term Debt History

Loading

Kissei Pharmaceutical , Ltd. vs. peers: Long Term Debt Comparison

Loading

Kissei Pharmaceutical , Ltd. Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Kissei Pharmaceutical , Ltd. (KSPHF) FAQ

The latest long-term debt for KSPHF is $460M as of June 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Kissei Pharmaceutical , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, KSPHF's long-term debt moved from $0 to $460M. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Kissei Pharmaceutical , Ltd.'s operating scale or balance-sheet position.

A long-term debt figure of $460M for KSPHF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting KSPHF's long-term debt ($460M), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.